2022 NILA Lab Leaders Forum

Join us for NILA’s first “live” meeting in over 2 years! Come meet with the Seegene Technologies team to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy for infectious diseases, respiratory infections, and STDs. Date May 14 – 15, 2022 Conference Venue: AT&T Hotel and Conference Center1900 University […]

The Pitfalls of At-Home COVID-19 Testing

Throughout the COVID-19 pandemic, identifying individuals who have been infected with SARS-CoV-2 in a reliable and timely manner has been a crucial strategy in controlling the spread of the disease. Over the course of the last two years, several at-home tests have been approved or authorized for individuals to quickly and easily test themselves for […]

2022 ASM Clinical Virology Symposium

2022 ASM CVS

2022 ASM Clinical Virology Symposium We are looking forward to meeting you at ASM CVS! The Seegene Technologies team will be set up at Booth 622, so come by to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy for infectious diseases, respiratory infections, and STDs. Date May 1-4, 2022 Conference […]

Seegene develops reagent detecting Covid-19 infection in 30 minutes

Published on Korea Biomedical Review Seegene, a multiplex molecular diagnostics company, said that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes. Seegene’s new product, Allplex SARS-CoV-2 fast MDx Assay, has obtained the Conformity European In-Vitro Diagnostics (CE-IVD) marking. The company plans to release it to the market after […]

Is the pandemic ending? Is COVID-19 now endemic?

After the global spikes in positive Omicron variant cases in December 2021 and January 2022, February saw a dip in the number of COVID-19 cases and deaths worldwide. In addition to this, several US states have lifted mask mandates. Large companies like Walmart and Amazon have dropped mask restrictions for fully vaccinated individuals. As of […]

The BA.2 Omicron Variant: Here’s What You Should Know

Although the “original” BA.1 subvariant of Omicron is the dominant form of the SARS-CoV-2 variant worldwide, a subvariant, BA.2 is now spreading rapidly in Asia and in parts of Europe and is reported to be the dominant form of SARS-CoV-2 in Denmark. Cases in India and the UK are on the rise. The subvariant has […]

What experts are saying about the flu-COVID-19 “twindemic”

In 2020, the news broke that the Pfizer and Moderna SARS-CoV-2 vaccines had reached historic milestones. This began the conversation about a roll-out plan and how our lives would be impacted moving forward. At that point in time, many schools around the US were still closed, many workers were still remote and mask-wearing restrictions were […]

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Novaplex SARS-CoV-2 Variant assay mutations coverage table includes mutations consistent with Omicron, Stealth Omicron, Alpha, Beta, Gamma and Delta variants

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron and […]

Omicron Variant: Letter to our customers

To Our Valued Seegene Customer, The World Health Organization has identified the Omicron variant (B.1.1.529) as the latest strain of the SARS-CoV-2 virus to be designated as a Variant of Concern. As the first cases are emerging in the US, Seegene confirms that the performance or quality of the Seegene EUA Allplex™ 2019-nCoV Assay is […]